Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Lung Cancer Early Detection, Early-Stage Radiation

Harvey Mamon

MD, PhD

🏢Dana-Farber / Brigham and Women's Cancer Center🌐USA

Associate Professor of Radiation Oncology

55
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Harvey Mamon focuses on stereotactic body radiation therapy for early-stage, screen-detected non-small cell lung cancer and gastrointestinal tumors. He has helped shape treatment paradigms for medically inoperable stage I NSCLC discovered during LDCT screening. He is an active clinical investigator at Dana-Farber.

Share:

🧪Research Fields 研究领域

SBRT early lung cancer
stereotactic radiation
screen-detected cancer management
radiation oncology
node-negative NSCLC

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Harvey Mamon 的研究动态

Follow Harvey Mamon's research updates

留下邮箱,当我们发布与 Harvey Mamon(Dana-Farber / Brigham and Women's Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment